Felipe Tapia Cáceres, PhD, has a diverse work experience spanning different roles and industries. Felipe started their career in 2015 with part-time work at Farmacias Ahumada. From December 2015 to February 2016, they served as the Director Técnico de Farmacia at Farmacias Knop Ltda., where they were responsible for medication dispensing, compliance with health regulations, and managing financial resources for the location.
In 2016, Felipe joined Farmacias Cruz Verde as a Director Técnico, holding the position from March 2016 to September 2017. During their time there, they continued to oversee compliance with health regulations and contribute to the smooth functioning of the pharmacy.
In 2017, Felipe embarked on a research career, starting as a Research Assistant at Monash University in April 2021. Felipe then pursued a PhD in November 2017 and completed it in July 2021. As a PhD candidate and Research Assistant, they gained valuable experience in academic research and worked on various projects related to their field of study.
Most recently, Felipe has joined Exopharm Ltd as a Research Scientist in October 2022. Their current role involves conducting research and contributing to the scientific advancements of the company.
Throughout their career, Felipe Tapia Cáceres, PhD, has demonstrated a commitment to research and has gained valuable experience in both academic and industry settings.
Felipe Tapia Cáceres, PhD has an impressive education history. Felipe completed their Doctor of Philosophy (PhD) in an unspecified field at Monash University. Additionally, they earned a second PhD from the same institution. Prior to their work at Monash University, Felipe attended Universidad de Chile where they obtained a degree as a Pharmaceutical Chemist, with the distinction of being approved with the highest honors. Felipe also obtained a Bachelor's degree in Pharmaceutical Sciences, again with distinction. In terms of additional certifications, Felipe received the IELTS (International English Language Testing System) certification from the British Council in September 2021.
Sign up to view 0 direct reports
Get started